SELEXIS — SUREcode
A technology reimagined as prophecy.
PRELUDE: THE IMPOSSIBLE
Biotech should be cautious. Silent. Invisible. But when you stare into the code of life, silence becomes hubris. SUREcode didn’t just validate cells — it redefined what “stable” means. It’s genetic auditing as ritual, a system that sees what others cannot.
ACT I: THE ENGINE
Selexis’s SUREtechnology Platform is built on Selexis Genetic Elements (SGE) — DNA-based elements that modulate chromatin arrangement to control expression stability and boost production. They can engineer a production-ready cell line in weeks, not months. They fully sequence their proprietary CHO-M cell line to map integration, support regulatory filings, and assure clonality. SUREcode is the layer above all this — the audit, the integrity checker. It’s code that reads code.
ACT II: THE VISUAL
We visualized SUREcode as data made visible. Blue screens, flowing code streams, glowing alerts, and windows of warning. The typography isn’t decorative — it’s part of the machine. The main imagery feels like a neural network’s rails, pulsing, watching. Each interface, each alert box, each red flag — part of the narrative: nothing escapes the code.
ACT III: THE PROPHECY
When this campaign launched, scientists didn’t see an ad. They saw the system turned on. SUREcode became the mythic overseer of the lab — the spectral sentinel scanning genomes, validating every transgene, preparing biopharma for what comes next. It doesn’t ask for trust. It demands accountability.
Credits: Concept, visual language, and art direction by Arash Giani.
Catalogue No. 012 / SIGNA ARCHIVE / SELEXIS SUREcode SERIES / 2025